Hyperrab 300 unit/ML vialml
Ended Awarded
- Contract number
- SPE2DR26F7WNL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,368
Award facts
- Contract value 100% obligated
- $5,367.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,367.52 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial on November 14, 2025, with an ultimate completion date of December 8, 2025. This firm fixed price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HYPERRAB is a rabies immunoglobulin product used for post-exposure prophylaxis in military and federal healthcare settings.
This delivery order is issued under AmerisourceBergen's comprehensive $999,999,999.00 IDC with DLA Troop Support Medical (contract SPE2DX), which runs through December 2026 and serves as a global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen is one of the nation's largest pharmaceutical distributors and holds significant responsibility for supplying vaccines, medications, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal health systems. The competitively awarded IDC demonstrates the vendor's capability to meet federal procurement requirements and supports DLA's strategic approach to pharmaceutical supply chain management across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F7WNL?
SPE2DR26F7WNL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F7WNL worth?
The government has obligated $5,368 on SPE2DR26F7WNL.
Is contract SPE2DR26F7WNL an order under another contract?
Yes. SPE2DR26F7WNL is a delivery order under SPE2DR25D7061, an indefinite delivery contract.
Was contract SPE2DR26F7WNL competed?
The extent of competition for SPE2DR26F7WNL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award